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who did not, and (2) between smokers who succeeded in their smoking cessation 
attempts and those who did not. RESULTS: Among smokers, 60.8% made 
smoking cessation attempts and 17.9% succeeded. Being younger, married, 
having health insurance, BMI (Body Mass Index) > 25kg/m2, and having a health 
care provider were independent and significant predictors of both quitting 
attempts and quitting success. African American race and having children in the 
household were positively and significantly associated with quitting attempts 
but had an inverse relationship with quitting success. Additional significant 
predictors of quitting attempts were Hispanic ethnicity and the presence of 
smoking-related diseases. Social support was an additional predictor of quitting 
success. CONCLUSIONS: Our findings indicate that some predictors related to 
smoking cessation attempts and successful smoking cessation were different. 
Sub-groups of patients (e.g. ethnic minorities, patients with smoking-related 
disorders, patients with children) might be motivated to initiate smoking 
cessation but might particularly benefit from additional support such as 
pharmacological interventions.  
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OBJECTIVES: To evaluate the accuracy of patients as reporters of health care 
utilization compared to administrative claims data in a sample of patients with 
chronic obstructive pulmonary disease (COPD). METHODS: This study consisted 
of a cross-sectional patient survey linked to respondents’ claims data for 12 
months prior to the survey date. Administrative claims from the HealthCore 
Integrated Research Database were utilized to identify commercially insured 
patients aged ≥40 with ≥1 medical claim with a COPD ICD-9-CM diagnosis code or 
≥1 pharmacy claim for COPD maintenance medication. Consenting patients 
completed a 25-minute survey including questions about the number of 
hospitalizations and ER visits 12 months prior to the survey. For reported 
hospitalizations and ER visits, respondents answered an additional question 
assessing whether the event was COPD-related. All-cause hospitalizations and 
ER visits were defined as hospitalizations or ER visits for any reason during the 
12 months prior to the survey, whereas COPD-related hospitalizations and ER 
visits required ≥1 medical claim with a COPD ICD-9-CM primary diagnosis code. 
RESULTS: Of 725 patients with both survey and claims data, 25.8% reported ≥1 
hospitalization on the survey in the 12 months prior compared to 23.6% with ≥1 
hospitalization for the same period using claims data. COPD-related 
hospitalization was 9.8% for survey data, 4.7% for claims. Using claims data as 
the gold standard, self-reported all-cause hospitalization showed high sensitivity 
(144 of 171, 84.2%) and specificity (511 of 554, 92.2%). COPD-related sensitivity 
was lower (67.6%) but had similar specificity (93.1%). Sensitivity and specificity of 
self-reported ER visits was lower but results were similar for both all-cause and 
COPD-related ER visits (all-cause: sensitivity 63.4%, specificity 89.2%; COPD-
related: sensitivity 68.4%, specificity 91.9%). CONCLUSIONS: Findings show that 
self-reported and claims data correspond well with respect to all-cause 
hospitalization; however, ER visits and disease-specific hospitalization may not 
correspond as well with claims.  
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OBJECTIVES: Asthmatics are at increased risk of FMD, which is further 
associated with poor self-management, risky behaviors, and future risk of 
asthma exacerbations. There is limited understanding of factors contributing to 
FMD in asthmatics. The study examines if FMD risk is increased with worsening 
levels of “asthma control”, taking into consideration comorbidity, psychosocial 
and demographic factors among active asthmatics. METHODS: Weighted data of 
active asthmatic adults (≥18 years) was derived from Behavioral Risk Factor 
Surveillance System-Asthma Call-Back Survey, 2008-09. Active asthmatics were 
adults reporting at-least one asthma related activity (symptoms, medication, or 
physician visit) in past year. Asthma control was categorized as well-controlled, 
not well-controlled, and very poorly-controlled asthma (VPCA), as per National 
Heart, Lung and Blood Institute-Expert Panel Report-3. Asthmatics diagnosed 
with COPD/Emphysema/Bronchitis were classified as having comorbidity. FMD 
was defined as “mental health not good due to stress, depression, or any 
emotional problem for ≥14 days in past 30 days”. Bivariate and multivariate 
logistic regression analyses were performed using SAS® 9.3. RESULTS: Among 
active asthmatics (N=27,100,135), 28.27% had VPCA, and 18.18% had FMD. 
Proportion of VPCA was significantly higher in; elderly, unmarried, unemployed, 
low-income, obese, smokers, and in those; having comorbidity, lacking 
emotional/social support, and lacking physical activity. After controlling for 
covariates, VPCA (OR=1.49, p=0.0004), increased FMD risk, while key psychosocial 
factors like emotional/social support (OR=0.28, p<0.0001) and physical activity 
(OR=0.70, p=0.0010) decreased FMD risk. Demographics at increased FMD risk 
were: non-elderly, females, unemployed, low-income, smokers, depression 
history. Comorbidity showed no significant association with FMD. 
CONCLUSIONS: VPCA imposes significant mental-burden on Active Asthmatics. 
Appropriate asthma care integrated with psychological support should be 
ensured to this group. Behavioral strategies like non-smoking, physical activity 
should be ensured by policy-makers, especially because they also decrease FMD 
risk. Future studies should explore psychological interventions that can benefit 
respiratory and mental health of asthmatics.  
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OBJECTIVES: IPF is a rare, progressive and ultimately fatal, pulmonary disease. 
New treatments are needed to relieve symptoms. Characteristic symptoms of IPF 
include breathlessness on exertion and cough. No instrument to quantify the 
nature, severity, and pattern of daily respiratory symptoms in IPF patients or the 
effect of treatment on these outcomes exists. The EXACT, a PRO instrument, 
assesses respiratory symptoms in patients with chronic obstructive pulmonary 
disease. This study examined the extent to which the EXACT might be useful as 
a symptom outcome measure in IPF. METHODS: Individual interviews were 
performed in two phases. During phase one, participants were recruited through 
IPF patient support groups and associations (n=20). In phase two, patients with 
high resolution computer tomography and/or biopsy-confirmed IPF were 
enrolled through an academic pulmonary clinic (n=10). All patients completed a 
telephone interview, including concept elicitation of daily IPF symptoms 
followed by a cognitive interview with the EXACT. RESULTS: The study included 
30 IPF patients in the US; mean (SD) age=68.0 (8.56) years; 40% female; 90% white. 
Mean (SD) FVC % predicted=57.5 (9.37); years since IPF diagnosis=2.5 (1.84). 
Across all interviews, respiratory symptoms identified during concept elicitation 
mapped to each of the respiratory items comprising the EXACT; no new 
symptoms were identified. An unexpected result was the prevalence and 
relevance of sputum production as a symptom. During cognitive interviews, 
participants found the items clear, interpretable, and relevant. CONCLUSIONS: 
Results of this qualitative study suggest EXACT items may be suitable for 
assessing respiratory symptoms in clinical studies of IPF patients. Next steps 
include quantitative research to determine structure and scoring of the EXACT-
IPF and score reliability, validity, and responsiveness. Adapting an existing PRO 
instrument can be an efficient and effective method for overcoming challenges 
associated with instrument development in rare disease populations.  
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OBJECTIVES: Craving for smoking is often considered as an important concept in 
smoking addiction and the most prominent and bothersome symptom 
experienced during the abstinence attempt. This study tries to evaluate the 
Malay version of the Brief Questionnaire on Smoking Urges (QSU-Brief). 
METHODS: A cross-sectional study design was adopted for the conduct of the 
study. The reliability and validity of Malay version for the questionnaire was 
evaluated based on the data collected from 133 participants. Cronbach’s alpha 
coefficient was calculated to assess the reliability. In order to assess the validity 
of the scales, Factor analysis and concurrent validity was employed to validate 
the psychometric properties of the scales. RESULTS: The Malay version of QSU-
Brief scale has good reliability with Cronbach’s alpha of 0.82. The test-retest 
reliability for the scale were presented an acceptable reliability and stability of 
the translated scale with spearman’s rank correlation coefficient with r=0.757 
(P<0.001). Furthermore, there was a significant positive correlation between 
carbon monoxide level, FTND total score and number of cigarettes smoked per 
day with MNWS total score (r=0.63, r=0.58 and r=0.62, P<0.001; respectively). 
Surprisingly, principal components analysis with orthogonal rotation yielded  
a uni-dimensional model which includes all the items of QSU-Brief. 
CONCLUSIONS: The findings from the current validation study revealed that the 
Malay version of the QSU-Brief are reliable and valid measure for the smoking 
urges and ready for use in clinical practice and research study.  
 
PRS42  
ASSESSMENT OF NIGHTTIME AND EARLY MORNING SYMPTOMS AMONG 
PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE  
Sullivan SD1, Cai Q2, Mocarski M3, Stephenson JJ2, Tan H2, Doshi, JA4 
1University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, 
USA, 2HealthCore, Inc., Wilmington, DE, USA, 3Forest Research Institute, Jersey City, NJ, 
USA,4University of Pennsylvania, Philadelphia, Pennsylvania, USA 
OBJECTIVES: To assess the pattern and impact of nighttime (NT) and early 
morning (EM) symptoms in patients with chronic obstructive pulmonary disease 
(COPD). METHODS: This study consisted of a cross-sectional patient survey. 
Administrative claims from the HealthCore Integrated Research Database were 
utilized to identify a patient sample list of commercially-insured patients, aged 
≥40 years, with ≥1 medical claim with an ICD-9-CM diagnosis code of COPD or ≥1 
pharmacy claim for COPD maintenance medication between September 1, 2010 
to August 31, 2011. Patients with potentially confounding diseases were excluded 
(e.g., respiratory cancer). Consenting respondents completed a 25-minute survey 
that included screening questions classifying them as having NT and/or EM 
symptoms. Survey recruitment was stratified based on NT/EM symptoms to 
maximize balance across groups. Respondents with NT/EM symptoms were 
asked about symptoms at night or early morning, as well as the severity and 
impact of their symptoms. RESULTS: Of 752 respondents completing the survey, 
